HeartBeam Inc.
BEAT
HeartBeam is a medical technology company focused on transforming cardiac care through the power of personalized insights. Our aim is to deliver innovative, higher resolution ambulatory cardiac monitoring solutions that can be used by patients anywhere to enable the detection and monitoring of cardiac disease outside of a healthcare facility.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$18M
▼ -8.1% YoY
Op. Margin
–
ROIC
-327.35%
▼ -606.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$13M
▲ +0.6% YoY
Op. Cash Flow (TTM)
-$12M
▲ +3.3% YoY
Net Debt
-$6M
Net Cash Position
Cash & Equiv.
$6M
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with BEAT
HeartBeam (BEAT) in two numbers
Questions about HeartBeam
Does HeartBeam (BEAT) pay a dividend?
No. HeartBeam (BEAT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 10 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in BEAT's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BEAT
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.